SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001193125-22-220196
Filing Date
2022-08-15
Accepted
2022-08-12 20:31:34
Documents
20
Period of Report
2022-08-10
Items
Item 1.01: Entry into a Material Definitive Agreement
Item 8.01: Other Events
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 8-K d333866d8k.htm   iXBRL 8-K 33655
2 EX-5.1 d333866dex51.htm EX-5.1 15690
3 EX-10.1 d333866dex101.htm EX-10.1 369392
4 EX-10.2 d333866dex102.htm EX-10.2 88960
5 EX-99.1 d333866dex991.htm EX-99.1 6903
6 EX-99.2 d333866dex992.htm EX-99.2 7916
10 GRAPHIC g333866g09u35.jpg GRAPHIC 2996
11 GRAPHIC g333866g78g76.jpg GRAPHIC 15290
12 GRAPHIC g333866sp3.jpg GRAPHIC 2868
  Complete submission text file 0001193125-22-220196.txt   807950

Data Files

Seq Description Document Type Size
7 XBRL TAXONOMY EXTENSION SCHEMA atnx-20220810.xsd EX-101.SCH 2857
8 XBRL TAXONOMY EXTENSION LABEL LINKBASE atnx-20220810_lab.xml EX-101.LAB 17995
9 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE atnx-20220810_pre.xml EX-101.PRE 11262
14 EXTRACTED XBRL INSTANCE DOCUMENT d333866d8k_htm.xml XML 3338
Mailing Address 1001 MAIN STREET SUITE 600 BUFFALO NY 14203
Business Address 1001 MAIN STREET SUITE 600 BUFFALO NY 14203 716-898-8625
Athenex, Inc. (Filer) CIK: 0001300699 (see all company filings)

IRS No.: 431985966 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-38112 | Film No.: 221161972
SIC: 2834 Pharmaceutical Preparations